Narayana Hrudayalaya enterprise value

Share price at each year-end

Tap a line for its trend	Currentlast 12M	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus


33,822	—	—	—	—	FY22 and earlierEvery year the company has filed comes with Alpha Plus.
1,542	1,184	1,437	1,104	406
2.5	2.3	1.9	1.4	1.0
4,866	4,866	2,213	1,444	762
37,148	—	—	—	—
3,324	3,682	776	340	356
₹1,817.77	—	—	—	—

9,871	9,406	5,842	4,329	2,895
49.3%	51.7%	37.9%	33.4%	26.3%
0.13×	—	—	—	—

3.62×	—	—	—	—
19.54×	—	—	—	—
28.45×	—	—	—	—
49.96×	—	—	—	—
10,273	7,896	5,483	5,018	4,525
1,901	1,617	1,276	1,152	966
1,306	1,169	998	910	756
—	1,618	990	1,067	1,085
744	744	−83.7	96.0	563
—	716	−102	87.9	554
—	875	1,074	971	522

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

NH₹1,655.00

Narayana Hrudayalaya Ltd.

· Pharma & Health

₹ CrorePeersAPOLLOHOSP MAXHEALTH FORTIS NEULANDLAB NATCOPHARM LALPATHLAB SAILIFE COHANCEMcap ₹33,822 Cr

HighlightsEnterprise Value Multiples Per ShareAnnuals · FY-end closes

In ₹ Crore except Per Share 12 Months Ending	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Current/LTM TTM · last close
Market Capitalization	—	—	—	—	33,821.7
- Cash, Equiv & ST Investments	406.1	1,103.5	1,437.2	1,184.3	1,542.2
+ Minority Interest	1.0	1.4	1.9	2.3	2.5
+ Total Debt	762.2	1,443.7	2,213.4	4,866.1	4,866.1
Enterprise Value	—	—	—	—	37,148.1
Net Debt (memo)	356.1	340.2	776.1	3,681.7	3,323.8
EV per Share	—	—	—	—	1,817.77

Total Capital	2,894.7	4,328.8	5,841.6	9,405.6	9,871.5
Total Debt/Total Capital	26.33	33.35	37.89	51.74	49.29
Total Debt/EV	—	—	—	—	0.13

EV/Sales	—	—	—	—	3.62
EV/EBITDA	—	—	—	—	19.54
EV/EBIT	—	—	—	—	28.45
EV/Free Cash Flow	—	—	—	—	49.96
Reference Items — Trailing FY Values
Sales	4,524.8	5,018.2	5,483.0	7,896.0	10,272.6
EBITDA	965.8	1,152.4	1,276.4	1,616.7	1,900.8
EBIT	755.8	910.2	998.3	1,168.9	1,305.7
Operating Cash Flow	1,084.6	1,066.6	990.1	1,618.5	—
Free Cash Flow	562.5	96.0	-83.7	743.5	743.5
FCFF (free cash flow to the firm)	554.2	87.9	-101.8	716.4	—
Capital Expenditure	522.0	970.6	1,073.8	874.9	—

Market Cap/EV/multiples pair each (split/bonus-adjusted) FY-end close with the latest filed share count; Current column uses the last close. Market Capitalization is a market-level figure — identical across Consolidated/Standalone (the accounting rows below differ). No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.